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Abstract: Growth in the first year of life may already be predictive of obesity later in 
childhood. The objective was to assess the association between prenatal exposure to various 
endocrine disrupting chemicals (EDCs) and child growth during the first year. Dichloro-
diphenyldichloroethylene (DDE), mono(2-ethyl-5-carboxypentyl)phthalate (MECPP), 
mono(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP), mono(2-ethyl-5-oxohexyl)phthalate 
(MEOHP), polychlorinated biphenyl-153, perfluorooctanesulfonic acid, and perfluoro-
octanoic acid were measured in cord plasma or breast milk. Data on weight, length, and head 
circumference (HC) until 11 months after birth was obtained from 89 mother-child pairs. 
Mixed models were composed for each health outcome and exposure in quartiles. For 
MEOHP, boys in quartile 1 had a higher BMI than higher exposed boys (p = 0.029). High 
DDE exposure was associated with low BMI over time in boys (0.8 kg/m2 difference at 11 
m). Boys with high MECPP exposure had a greater HC (1.0 cm difference at 11 m) than 
other boys (p = 0.047), as did girls in the second quartile of MEHHP (p = 0.018) and DDE (p 
< 0.001) exposure. In conclusion, exposure to phthalates and DDE was associated with BMI 
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as well as with HC during the first year after birth. These results should be interpreted with 
caution though, due to the limited sample size. 
Keywords: endocrine disruption; prenatal exposure; BMI; head circumference;  
early childhood 
 
1. Introduction 
Optimal development and health early in life are key factors for health and wellbeing during 
childhood and adulthood. It has been hypothesized that adult health and disease have their origin in the 
prenatal and early postnatal environment, a concept referred to as the Developmental Origins of Health 
and Disease [1]. This is illustrated by the Dutch Hunger Winter Study, in which exposure to famine 
during gestation was associated with an increased risk for amongst others coronary heart disease and 
obesity [2]. These associations were furthermore dependent on the timing of the famine during 
gestation, as they were only observed for those exposed early in pregnancy. 
There are various parameters early in life which are indicators for development later in life. Birth 
weight, for example, is inversely associated with hypertension [3] and type 2 diabetes [4] in adulthood, 
and both high [5] and low [6] birth weight are associated with obesity. Rapid growth in infancy, in 
terms of both weight and height, is considered an independent risk factor for childhood obesity [7,8].  
A recent study by Gittner et al. showed that children who were obese at the age of five years already 
had distinct body mass index (BMI) patterns before 12 months of age. Children who had a normal 
BMI at age five always had a lower BMI from age 6 months and onwards compared to children who 
were obese at age five years [9]. They furthermore showed that BMI patterns over time differed 
between male and female children, with female children who were overweight at the age of five 
gaining weight faster in the first two years of life compared to male overweight children [9].  
Childhood obesity has also been related to exposure to endocrine disrupting chemicals (EDCs)  
early in life. Several studies have observed positive associations with BMI and early childhood  
growth for chemicals such as organochlorine pesticides (e.g., dichlorodiphenyltrichloroethane (DDT), 
hexachlorobenzene (HCB)) [10–13] and perfluorinated alkyl acids (PFAAs) [14]. On the other hand 
several studies have reported no effect [15–18], as we have described in a recently published  
review [19]. Furthermore associations seem to differ between males and females, and dose-response 
relations are not clear. Exposure to these chemicals is widespread. The organochlorine pesticides, such 
as DDT, of which dichlorodiphenyldichloroethylene (DDE) is the major metabolite, and HCB, have 
been banned from production [20,21], but remain in the food chain due to their lipophilic and 
bioaccumulating properties. DDT is furthermore still in use in developing countries for vector control 
(malaria) [22]. Polychlorinated biphenyls (PCBs), which were mainly applied as dielectric and coolant 
fluids and which were banned due to their carcinogenic characteristics [23], have also bioaccumulated 
in the food chain [24]. Exposure to these chemicals is slowly decreasing over time, however it is not 
certain if low dose exposure implies safe exposure [25]. Not all EDCs are persistent, though exposure 
to non-persistent EDCs may occur on a continuous basis. Examples of these are phthalates which are 
used to soften plastics, and perfluorinated alkyl acids (PFAAs), surfactants used in various consumer 
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products. Furthermore, the presence of many chemicals, such as PFAAs, PCBs, organochlorine pesticides, 
and phthalates, can be detected in 99%–100% of pregnant women [26]. As several of these chemicals 
have also been detected in e.g., cord blood [12,27] and amniotic fluid [28,29], it is clear that the 
placenta does not protect the fetus from these exposures [30,31]. EDCs are suspected—as implied by 
their name—to disrupt hormonal action, and exposure early in life may have long lasting effects [32]. 
Experimental studies have furthermore shown that they may cause epigenetic changes [33], which 
implies that effects of these chemicals may potentially be trans-generational. 
In light of prevention, it is essential to determine to which extent EDCs affect child growth as early 
as in the first 12 months after birth. As infants in the Netherlands are eligible for free health monitoring 
by youth health care organizations, each child is measured and weighed regularly, especially in the 
first twelve months. The objective of this study was to determine possible associations between markers 
of prenatal exposure to various EDCs and child growth in the first year of life. The compounds 
included were DDE, PCB-153, three metabolites of di(2-ethylhexyl) phthalate (DEHP), including 
mono(2-ethyl-5-carboxypentyl)phthalate (MECPP), mono(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP), 
and mono(2-ethyl-5-oxohexyl)phthalate (MEOHP), as well as the PFAAs perfluorooctanesulfonic acid 
(PFOS), and perfluorooctanoic acid (PFOA).  
2. Methods 
2.1. Study Procedures and Subjects 
Six midwifery clinics in the area of Zwolle, the Netherlands, participated in the recruitment of 
pregnant women, which started in January 2011 and finished in January 2013. The Zwolle community 
is located in the “Salland” area, which is characterized by a relatively low level of urbanization. 
Women were invited to participate during the first antenatal visit to the midwife (between 10 and 12 
weeks of pregnancy) and were considered eligible for participation if they were able to fill out Dutch 
questionnaires. In total 148 mother-child pairs were included. Twin pregnancies and major congenital 
anomalies were reasons for exclusion, however no participant was excluded because of these criteria. 
Signed informed consent was obtained from every participant. Cord blood and breast milk were 
collected for determination of markers of early life exposure to several EDCs. Youth health care 
organizations in the area of Zwolle were approached for data on growth during the first year which 
they collect during scheduled follow-up visits of each child in the Netherlands. About 99.5% of parents 
in the Netherlands visit youth health care centres with their child during the first year [34]. On average 
each child is seen six times during this period. Information on parental anthropometry was obtained 
from the midwives, and questionnaires were administered during pregnancy to collect information on 
parental health and lifestyle, and previous pregnancies. Fourteen subjects dropped-out before delivery 
due to lack of time of the mother to participate, and for 45 subjects no exposure data was available, 
resulting in the inclusion of 89 mother-child pairs for analysis. The study was approved by the medical 
ethics committee of the VU University medical centre. 
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2.2. First Year Growth 
Data on weight, height (supine length), and head circumference were obtained from youth health 
care organizations. Parents were contacted by youth health care for follow-up visits at 1, 2, 4, 6, 9, and 
11 months after birth. Infant BMI was calculated from weight and height (BMI = weight (kg)/height2 (m2)).  
2.3. Chemical Exposure 
Umbilical cord blood was collected immediately after birth when the health of mother and child 
was ascertained. Midwives and nurses were instructed to collect as much blood as possible and to 
transfer it to EDTA tubes. The blood was delivered to the lab within twelve hours by a courier in case 
of home delivery or by hospital staff in case of delivery at the hospital. At the lab, cord blood was 
centrifuged for 10 min at 2000 g after which the plasma layer was transferred to plasma tubes. Plasma 
was stored at −80 °C. 
Breast milk was collected in the second month after birth (mean (SD): 6.3 (2.5) weeks). In total a 
minimum of 100 mL was collected, spread over five to ten days to minimize the burden to the mothers 
in case of low milk flow. Mothers were instructed to note the dates on which they collected a sample 
and to store the milk in the freezer in between sampling days. They were allowed to use a breast pump 
for collection. 
Compounds were analysed in cord plasma. For DDE we also analysed breast milk samples from 
mothers for whom an insufficient amount of cord blood was available. PFOA and PFOS were analysed 
by applying isotope dilution and large volume injection using an on-line trapping column coupled to 
liquid chromatography and triple quadrupole mass spectrometry. The isotope labelled standards  
13C4-PFOA and 13C4PFOS were obtained from Wellington Laboratories (Guelph, ON, Canada). The 
breast milk samples were extracted with solid phase extraction using Oasis WAX cartridges (Waters, 
Milford, MA, USA). For the cord plasma samples, the proteins were precipitated by adding methanol 
and centrifuging the mixture prior to injection onto the analytical system.  
After drying both the cord plasma and the breast milk samples with Kieselguhr (Supelco,  
Sigma-Aldrich, St. Louis, MO, USA), the organochlorine pesticide p,p’-DDE, and PCB153 were 
extracted with a mixture of dichloromethane and hexane. As internal standard, 13C12-PCB153, obtained 
from Cambridge Isotope Laboratories (Tewksbury, MA, USA), was used. Cleanup of the extracts was 
done using sulphuric acid silica columns and for the analysis gas chromatography with mass 
spectrometric detection in negative chemical ionization mode was used.  
For the analyses of the DEHP metabolites, enzymatic deconjugation was carried out. After addition 
of the internal standards used for isotope dilution, the breast milk samples were extracted using Oasis 
MAX (Waters) cartridges, while for the cord plasma samples a simple protein precipitation step using 
formic acid was applied. The isotope labelled standards 13C4-MEOHP, 13C4-MEHHP, 13C4-MECPP 
and MEHP‒d4 were all obtained from Cambridge Isotope Laboratories. The extracts were analysed 
after large volume injection using an on-line trapping column coupled to liquid chromatography and 
triple quadrupole mass spectrometry. Problems due to the occurrence of contamination of the breast milk 
samples are to be expected for mono(2-ethylhexyl)phthalate (MEHP), the hydrolytic monoester of 
DEHP, that has shown to also be formed in the matrix due to the residual activity of enzymes (lipases, 
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esterases), even after prolonged storage periods at −20 °C. Therefore, MEHP is a very unreliable 
parameter for the assessment of DEHP exposure and should not be used for breast milk. In contrast, 
MECPP, MEHHP, and MEOHP are not susceptible to contamination as they are major metabolites of 
DEHP created by the liver. They are only formed in vivo and serve as a reliable parameter for  
DEHP exposure.  
The coefficient of variation for the chemicals measured, was 16%–17%. More information on 
chemical analysis, including limits of quantification and quality control parameters, is given in the 
Supplemental Material, pp. 2–4.  
2.4. Data-Analysis 
Data-analysis was performed using IBM SPSS version 20 (Armonk, NY, USA) [35]. For each 
compound, exposure values below the limit of quantification (LOQ) were replaced by LOQ/√2 [36]. 
For DDE a conversion factor, based on publications of other European cohorts, was used to transform 
levels in breast milk to levels in cord blood, as it accumulates in lipid [36]. The following conversion 
factor was used: 
[DDE, cord plasma (ng/L)] = 1.20 × [DDE, breast milk (ng/g lipid)] [36] 
For PCB-153, over 50% of the cord plasma samples had an exposure level that could not be 
quantified. As PCB-153 was determined predominantly in cord blood it was decided to only include 
cord blood levels of PCB-153 and to dichotomize at LOQ (>LOQ vs. <LOQ). For the other 
compounds no conversion factor was applied and only cord blood levels were used.  
Mixed models were used for the main analysis. For each compound a separate model was 
composed for weight, height, BMI, and head circumference. Linearity with outcome was checked for 
each compound, and as none of the compounds showed a linear association, each exposure was split 
up in quartiles. Exposure quartiles, timing of anthropometric measurement, sex and their interactions 
were added to the models as fixed effects and a random effect was added for subject. Time was 
included as a categorical variable. Covariates were selected based on literature and included 
maternal/paternal BMI and height, birth weight, gestational age, parity, alcohol, smoking, education, 
and breast feeding duration. As sample size was relatively small, covariates were only added to the 
models if they were deemed relevant (change in β-coefficient of exposures > 10%). Using this cut-off, 
birth weight, gestational age, and maternal height influenced the estimates in the majority of analyses 
and were therefore selected for all models. Sex and time specific marginal means were calculated from 
the models and were used to plot the development over time in growth parameters for the exposure 
quartiles and for boys and girls separately. Interactions were considered significant at a p-value of 
0.10, considering the limited power of this study. 
2.5. Covariates 
Birth weight was measured after birth by a midwife or a nurse and was obtained from registries of 
the midwives. Newborns were put on the weighing scale without a diaper and birth weight was 
determined when the infant was in a calm state. Weighing scales were provided by the midwives and 
were calibrated daily. Gestational age was determined by midwives by means of early ultrasound. 
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Maternal height was measured by the midwife at inclusion, approximately 10–12 weeks in 
pregnancy. Midwives received a measuring tape which was attached to a wall in the midwife’s office, 
as well as instructions on how to perform this measurement, including how the participants should be 
positioned and the precision required for the measurement.  
3. Results 
Out of the 89 children included in the analysis, 56 were boys (Table 1). Compared to girls, boys had 
a higher weight gain between 1 and 11 months of age (5.3 versus 4.5 kg), as well as a larger increase in 
height (21.5 versus 19.7 cm) and head circumference (9.0 versus 8.1 cm). The majority of the children 
were breastfed for a period longer than three months (boys: 69.2%, girls: 64.3%).  
An overview of exposure levels of the various compounds is given in Table 2. Information on 
exposure quartiles is given in Table 3. Due to the high fat content of breast milk samples, wet weight 
levels of the lipophilic compound DDE were lower than lipid corrected levels. There was no difference 
in exposures between boys and girls (not shown).  
Table 1. Population characteristics of the study cohort. 
 Boys (n = 56) Girls (n = 33) 
Weight, age = 1 month (kg) 4.68 (3.00–5.87) 4.25 (3.21–5.38) 
Weight, age = 11 months (kg) 10.13 (8.49–12.85) 8.92 (6.88–10.55)
Weight gain, first year (kg) 5.31 (4.16–7.59) 4.46 (3.41–5.60) 
Height, age = 1 month (cm) 54.8 (51.0–59.0) 53.9 (51.0–59.9) 
Height, age = 11 months (cm) 76.6 (71.0–81.4) 74.6 (71.0–77.0) 
Growth, first year (cm) 21.5 (18.0–25.0) 19.7 (16.0–23.3) 
BMI, age = 1 month (kg/m2) 15.5 (12.8–18.7) 14.8 (12.0–17.0) 
BMI, age = 11 months (kg/m2) 17.1 (15.6–21.0) 16.2 (13.3–18.5) 
BMI change, first year (kg/m2) 1.8 (−1.6–5.2) 1.6 (−0.8–3.2) 
Head circumference, age = 1 month (cm) 38.0 (34.2–40.6) 37.3 (35.1–40.1) 
Head circumference, age = 11 months (cm) 46.8 (43.4–49.5) 45.2 (42.6–48.0) 
Head circumference change, first year (cm) 9.0 (7.9–11.2) 8.1 (6.7–10.4) 
Birth weight (g)  3624.5 (491.7) 3564.2 (397.5) 
Gestational age (weeks) 39.7 (1.5) 40.1 (1.0) 
Parity (nulliparous, %) 23 (42.6%) 10 (30.3%) 
Height mother (cm) 171.4 (5.7) 171.9 (4.6) 
Height father (cm) 185.2 (6.8) 183.6 (6.2) 
BMI mother (start pregnancy, kg/m2) 23.6 (3.3) 23.0 (4.2) 
BMI father (kg/m2) 24.0 (3.0) 25.0 (2.8) 
Age mother (years) 30.3 (3.8) 31.9 (3.5) 
Age father (years) 32.4 (5.6) 34.2 (4.2) 
Breastfeeding   
No breastfeeding 4 (7.7%) 3 (10.7%) 
0–3 months breastfeeding 12 (23.1%) 7 (25.0%) 
>3 months breastfeeding 36 (69.2%) 18 (64.3%) 
Education mother (bachelor/master, %) 41 (75.9%) 19 (59.4%) 
Smoking (first trimester, yes, %) 2 (3.7%) 2 (6.1%) 
Alcohol (first trimester, yes, %) 3 (2.7%) 2 (6.6%) 
Unless stated otherwise, values are median (range) or mean ± SD. 
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Table 2. Exposure profile of the study cohort. 
Compound  n Mean Median Range LOQ <LOQ (%)
PCB-153        
Cord plasma  
ng/L 52 35.94 29.14 22.63–96.00 21–43 55.8 
ng/g lipid 52 36.31 31.04 17.95–88.89 14–53 55.8 
DDE        
Cord plasma  
ng/L 52 115.61 83.00 28.28–470.00 33–73 23.1 
ng/g lipid 52 116.16 82.06 28.83–580.25 23–86 23.1 
Breast milk 
ng/L 24 2527.92 1950.00 400.00–1,1390.00 9.20–13.00 0 
ng/g lipid 24 62.58 45.33 12.11–277.80 0.13–0.53 0 
Total a ng/L 76 102.82 74.50 14.53–470.00  15.8 
MECPP        
Cord plasma  ng/mL 61 0.31 0.27 0.11–1.00 0.13–0.28 6.6 
MEHHP        
Cord plasma  ng/mL 61 0.32 0.26 0.10–1.00 0.14–0.27 11.5 
MEOHP        
Cord plasma  ng/mL 61 0.29 0.22 0.12–0.87 0.17–0.33 26.2 
PFOA        
Cord plasma  ng/L 61 940.2 870.0 300–2700 50–140 0 
PFOS        
Cord plasma  ng/L 61 1611.0 1600.0 570–3200 44–140 0 
a For total DDE, cord plasma exposure data were merged with breast milk exposure levels converted to cord 
plasma levels.  
Table 3. Exposure quartiles. 
Compound Q1 n Q2 n Q3 n Q4 n 
DDE (Total) (ng/L) <44.74 19 44.74–74.50 19 74.51–113.11 19 >113.11 19
MECPP (ng/mL) <0.16 15 016–0.24 15 0.25–0.34 15 >0.34 15
MEHHP (ng/mL) <0.20 16 0.20–0.23 17 0.24–0.37 11 >0.37 17
MEOHP (ng/mL) <0.13 17 0.13–0.20 17 0.21–0.34 13 >0.34 14
PFOA (ng/L) <591 17 591–870 14 871–1100 15 >1100 15
PFOS (ng/L) <1001 18 1001–1600 15 1601–2000 14 >2000 14
PCB-153 was included as a dichotomous variable (<LOQ vs. >LOQ).  
3.1. BMI 
Sex-specific BMI curves for DDE, MECPP, MEHHP, and MEOHP are given in Figure 1A–D.  
For the other EDCs they can be found in the Supplemental Material pp. 5–6. For all compounds, 
significant main effects were observed for both time and sex, but not for compound (Table 4). We did 
find a relevant main effect for MECCP which was 1.5 and 2.2 at 11 months for boys and girls 
respectively (p = 0.051). Interaction effects were observed for total DDE and MEOHP.  
Total DDE showed an interaction with time, independent of sex, meaning that BMI differed 
between exposure quartiles over time (p = 0.078). Boys in the highest DDE exposure quartile had a 
BMI which was lower than boys with a lower DDE exposure at all ages (Figure 1A). At the age of  
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11 months, the difference with the nearest quartile reached 0.8 kg/m2 (mean BMI Q4: 16.8 kg/m2,  
95% CI 16.09 to 17.49; mean BMI Q3: 17.6 kg/m2, 95% CI 16.93 to 18.35). A similar result was 
observed for girls in the third exposure quartile. 
Figure 1. Sex specific BMI curves for early life DDE (A), MECPP (B), MEHHP (C) and 
MEOHP (D) exposure. 
 
(A) 
 
(B) 
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Figure 1. Cont. 
 
(C) 
 
(D) 
For MEOHP a significant interaction with time and sex on BMI was observed (p = 0.029), 
indicating that BMI differed between exposure quartiles during the first year, and that these patterns 
were different for boys and girls (Figure 1D). In boys, weight at one month of age was similar for all 
quartiles. However, from 3 months onwards, boys in the lowest exposure quartile showed a very 
deviant development in their BMI from all other boys and girls in the sample. On average their BMI 
was much higher.  
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Table 4. p-values of tests of main effects and interactions of compound with time, sex, or 
time and sex, for each health outcome. 
EDC Effect 
BMI Weight Height Head Circumference
p p p p 
DDE 
Time <0.001 * <0.001 * <0.001 * <0.001 * 
DDE 0.293 0.647 0.910 0.778 
Sex <0.001 * <0.001 * 0.024 * <0.001 * 
Time × DDE 0.078 * 0.84 0.490 0.721 
DDE × sex 0.420 0.205 0.484 0.905 
Time × DDE × sex 0.298 0.695 0.134 <0.001 * 
PFOS 
Time <0.001 * <0.001 * <0.001 * <0.001 * 
PFOS 0.586 0.802 0.975 0.649 
Sex <0.001 * <0.001 * 0.040 * <0.001 * 
Time × PFOS 0.878 0.910 0.485 0.800 
PFOS × sex 0.655 0.425 0.749 0.485 
Time × PFOS × sex 0.679 0.617 0.321 0.742 
PFOA 
Time <0.001 * <0.001 * <0.001 * <0.001 * 
PFOA 0.813 0.350 0.045 * 0.774 
Sex <0.001 * <0.001 * 0.019 * <0.001 * 
Time × PFOA 0.389 0.126 <0.001 * 0.001 * 
PFOA × sex 0.242 0.169 0.165 0.467 
Time × PFOA × sex 0.348 0.812 0.152 0.387 
MECPP 
Time <0.001 * <0.001 * <0.001 * <0.001 * 
MECPP 0.051 0.265 0.726 0.314 
Sex 0.004 * <0.001 * 0.002 * 0.003 * 
Time × MECPP 0.117 0.090 * 0.944 0.604 
MECPP × sex 0.496 0.277 0.185 0.047 * 
Time × MECPP × sex 0.204 0.929 0.978 0.886 
MEHHP 
Time <0.001 * <0.001 <0.001 * <0.001 * 
MEHHP 0.279 0.204 0.133 0.144 
Sex 0.005 * 0.002 0.163 0.012 * 
Time × MEHHP 0.593 0.962 0.294 0.100 * 
MEHHP × sex 0.383 0.326 0.073 * 0.197 
Time × MEHHP × sex 0.127 0.485 0.011 * 0.018 * 
MEOHP 
Time <0.001 * <0.001 * <0.001 * <0.001 * 
MEOHP 0.315 0.151 0.112 0.119 
Sex <0.001 * 0.001 * 0.390 <0.001 * 
Time × MEOHP 0.152 0.948 0.084 * 0.335 
MEOHP × sex 0.104 0.831 0.207 0.253 
Time × MEOHP × sex 0.029 * 0.037 * <0.001 * 0.240 
PCB-153  
(>LOQ vs. <LOQ) 
Time <0.001 * <0.001 * <0.001 * <0.001 * 
PCB 0.203 0.544 0.598 0.729 
Sex <0.001 * <0.001 * 0.001 * <0.001 * 
Time × PCB 0.491 0.518 0.946 0.861 
PCB × sex 0.338 0.738 0.115 0.586 
Time × PCB × sex 0.808 0.775 0.086 * 0.102 
* Main effects considered significant at p ≤ 0.05, interaction effects at p ≤ 0.10. 
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3.2. Weight and Height 
Sex specific weight and height curves for each compound can be found in the Supplemental 
Material pp. 7–14. Main effects of time and sex were significant for all compounds for both weight and 
height (Table 4). No main effects of exposure were observed, except for PFOA and height.  
For MEOHP results regarding weight and height were similar to BMI, showing a significant 
interaction with both time and sex in a similar direction.  
3.3. Head Circumference 
Sex-specific head circumference curves for DDE, MECPP, MEHHP, and MEOHP are given in 
Figure 2A–D. For the other EDCs they can be found in the Supplemental Material pp. 15–16. Similar 
to BMI, main effects for both time and sex on head circumference were significant for all compounds, 
whereas no main effects for exposure were observed (Table 4). Interaction effects were observed for 
total DDE, PFOA, MECPP, and MEHHP.  
For total DDE a significant interaction with time and sex on head circumference was observed  
(p < 0.001), indicating that head circumference differed between exposure quartiles during the first 
year, and that these patterns were different for boys and girls. Girls in the second quartile of exposure 
had a greater head circumference from six months onwards. Boys in the highest exposure quartile 
showed a similar pattern. 
Figure 2. Sex specific head circumference curves for early life DDE (A), MECPP (B), 
MEHHP (C) and MEOHP (D) exposure. 
 
(A) 
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Figure 2. Cont. 
 
(B) 
 
(C) 
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Figure 2. Cont. 
 
(D) 
Boys in the highest MECPP exposure quartile had a consistently greater circumference over time 
than the other boys (Figure 2B). Those in the lowest quartile on the other hand had a consistently 
smaller head circumference than the other quartiles. There was also a significant interaction for 
MEHHP exposure with time and sex (p = 0.018). In girls, the second exposure quartile in particular 
showed a consistently greater head circumference over time compared to the other quartiles  
(Figure 2C). At six months of age the difference compared to the two quartiles showing the smallest 
head circumference was 2.0 cm, which was not statistically significant (head circumference Q2:  
44.9 cm, 95% CI 43.2 to 46.7; head circumference Q3: 42.9 cm, 95% CI 42.2 to 43.5). 
4. Discussion 
The objective of this study was to determine the possible associations between early life exposure to 
various EDCs and child growth in the first year of life. This is, to our knowledge, the first study to 
examine prenatal phthalate exposure in relation to growth in early childhood. Importantly, in our study 
we have measured phthalate metabolites in cord blood, whereas most studies use maternal urine as a 
proxy for prenatal exposure. Although our sample was relatively small, our analyses revealed some 
potentially relevant findings. Phthalate metabolites were associated with both BMI and head 
circumference, with low exposure levels associated with higher BMI values, and high exposure levels 
associated with a greater head circumference. DDE exposure was also associated with BMI and head 
circumference, however patterns were less consistent. None of the compounds showed a linear  
dose-response relation with the outcomes included. 
For all growth parameters effects of DEHP exposure were observed. Low exposure levels in 
particular were associated with higher BMI values. We furthermore observed continuous increases in 
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BMI between 6 and 11 months of age for boys in the first and third exposure quartiles of all DEHP 
metabolites. Similar early life growth patterns have been observed for children who were overweight 
or obese when five years old, as observed in the study by Gittner et al. [9]. Reference BMI curves of 
the World Health Organization generally show a decline in BMI in the second half of the first  
year [37]. In this cohort, girls did show a stabilization of or a decline in BMI during the last six 
months. These results suggest that prenatal DEHP exposure may possibly predispose children, and 
perhaps boys in particular, to a more obese growth pattern. However, these results do need to be 
replicated in larger studies with more longitudinal follow-up as numbers in the current study are very 
low. Experimental studies have also indicated that maternal DEHP exposure in rodents leads to 
increases in body weight in offspring [38]. The biological mechanism underlying DEHP effects on 
obesity has been proposed to be through its activation of peroxisome proliferator-activated receptors 
(PPAR), master regulatory genes in lipid metabolism and adipocyte differentiation [38,39]. 
Early life exposure to phthalates was also related to changes in head circumference during the first 
year. In particular in boys and girls with the highest exposure to respectively MECPP and MEHHP 
exposure a higher head circumference was observed during the first year. We could not find any other 
studies which investigated this, except for a few papers which related prenatal exposure to head 
circumference at birth, but none of those showed any significant effect on head circumference at birth 
for MECPP, MEHHP, or MEOHP [40–43]. For MEHHP exposure, we observed a range of 2 cm 
across exposure quartiles at 6 months of age, and even though this difference was not significant,  
the absolute difference in itself is quite large as the range between P10 and P90 at this age in girls is 
3.4 cm according to the WHO reference tables [44]. Follow-up of these children is essential to see  
if these variations persist throughout childhood and to clarify whether these results are relevant 
regarding neurodevelopment. 
For DDE, a difference in BMI between exposure quartiles over time was observed. Boys highest 
exposed to DDE had a consistently lower BMI compared to their peers in the other quartiles, and for 
girls the third exposure quartile in particular showed less increase in BMI over time compared to the 
other girls. Several studies have reported no effect of prenatal DDE exposure on growth, including a 
cohort of Mexican boys with a median age of 18 months at follow-up [45], as well as another Mexican 
cohort with follow-up until 12 months of age [15]. DDE exposure in both these cohorts was however 
much higher than in our sample. Interestingly, however, our study indicated that lower exposures to 
DDE were associated with an increase in BMI between 6 and 11 months of age. Similarly, in the 
Spanish INMA cohort, with DDE levels similar to this cohort, prenatal exposure was associated with 
rapid weight gain in the first six months, and a higher BMI at the age of 14 months [10]. In Belgian 
children, prenatal DDE exposure was associated positively with BMI in 3-year-olds [27]. Animal 
studies have indicated that long term, multigenerational exposure to DDT results in weight gain in 
offspring, though biological mechanisms have not been elucidated [46]. 
Effects for PCB-153, PFOS, and PFOA were less evident. For PCB-153 changes in height were 
significant over time and sex. These differences between groups were however only visible during the 
first three months, after which results became similar for all groups. For the other growth parameters 
no effect was observed. For head circumference a deviation for PCB-153 curves was observed 
compared to curves for other compounds, which showed a continuous increase in head circumference 
over time, while a decrease was observed for PCB-153 between four and six months of age. This is 
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probably due to variations in the number of participants, which differs across quartiles as well as 
between compounds. The decrease was however insignificant. 
For PFOS, no significant interaction effects were shown, and even though for PFOA exposure 
quartiles developed differently over time regarding height and head circumference, variation between 
quartiles was relatively small. Studies regarding prenatal PFAA exposure and childhood 
anthropometry are scarce. Halldorsson et al. showed a positive association with BMI for 20-year-old 
women who were prenatally exposed to PFOA [14]. In the Danish National Birth Cohort inverse 
associations with BMI were seen for both PFOS and PFOA when the children were twelve months of 
age [47], however at seven years of age these associations were no longer apparent [18]. More research 
is required to elucidate whether prenatal PFAA exposure affects growth in children. 
Results of the current study showed some sex specific effects, which have also been observed in 
some previous studies. In a cohort of 7-year-old children from the Faroe Islands, associations between 
prenatal PCB and DDE exposure and BMI were only observed in girls, and in particular in girls who 
had mothers with a high pre-pregnancy BMI [48]. In the INMA cohort, higher exposures to DDE were 
related to an increased risk for overweight, and this result was strongest in girls [12]. Higher DDT 
exposure on the other hand, was associated with an increased risk for being overweight in boys only. 
As mentioned before, studies on prenatal phthalate exposure and obesity/overweight are not available, 
however in a cross-sectional study, Hatch et al. reported that exposure to various phthalates, as 
determined in urine, was positively associated to BMI in males aged 20–59 years, and in females aged 
12–19 years [49]. Not all studies report results stratified for sex, and as these compounds are suspected 
to disrupt the endocrine system—which is specific for males and females—future studies should aim 
to include sex specificity in their results. Further experimental research would also be important to 
understand mechanisms underlying the sex specific effects of EDCs.  
Various mechanisms are possible through which early life exposure to EDCs may affect anthropometry 
in a sex-specific fashion. Most EDCs are thought to have (anti-)estrogenic or (anti)androgenic properties. 
Studies in sheep have shown that prenatal exposure to testosterone is associated with lower birth 
weight, developmental changes in insulin-like growth factor (IGF)/IGF binding protein system, and 
insulin resistance (reviewed in [50]). In a recent study in which rats were developmentally exposed to 
the suspected androgen DEHP, female rats were observed to have impaired glucose tolerance and 
insulin secretion [51]. Male rats showed increased serum insulin levels, and both female and male rats 
had a significantly lower birth weight than controls. Environmental exposure to chemicals may also 
affect anthropometry through interference with glucocorticoids. Increased maternal glucocorticoid levels 
have been associated with lower birth weight and altered set-point of the hypothalamic-pituitary-adrenal 
(HPA) axis (reviewed in [52]). Hydroxy-PCBs have been shown to have anti-glucocorticoid properties 
in human placenta [53], whereas in adipocytes BPA and dicyclohexyl phthalate (DCHP) activated the 
glucocorticoid receptor and increased lipid accumulation [54].  
None of the compounds included showed a linear dose-response relation with any of the growth 
outcomes. This has however also been reported by other studies on early life EDC exposure and 
growth [14,16,55]. Nonmonotonic dose-response relations have been reviewed by VandenBerg et al. 
(2012), who indicate that the endocrine system is designed to work at low concentrations and that low 
dose effects cannot be predicted from effects observed at higher doses [25]. Whether the associations 
we observe are truly non-monotonic remains to be clarified by larger studies. 
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Models were adjusted for birth weight, as birth weight in itself may predispose individuals to a 
more obese growth pattern. However, several studies have shown that prenatal exposure to certain 
EDCs is associated with birth weight (see the meta-analysis by Govarts et al. [36]) and therefore birth 
weight may also be in the causal pathway between exposure and childhood obesity. Including this 
factor in the model would then lead to overcorrection. We therefore performed a sensitivity analysis 
for BMI without birth weight in the models (not shown), which did not affect any of the interaction 
effects, except between DDE and sex, which became significant, but no changes were observed in 
terms of relevance. For boys in the first quartile of PFOA exposure, and the third quartile of both 
PFOS and MEHHP exposure, a higher BMI was observed compared to the other groups if birth weight 
was not included in the models. These quartiles where however also relatively high when birth weight 
was included in the models. 
A limitation of this study is the small sample size. As associations between outcomes and exposures 
were not linear, participants were divided in quartiles based on exposure levels. This also reduced the 
power. In addition, cut points were therefore not based on clinical relevance which might have 
obscured real effects or evoked non-relevant effects. However, no accepted cut-off level exists to our 
knowledge. Moreover we stratified results for sex, which reduced power of the tests. However, as 
growth differs between boys and girls and the chemicals in question may affect the endocrine system, 
stratification was necessary. Finally, our inclusion of covariates in the model could have potentially 
further reduced power. However standard errors were not affected by including them into the models. 
They were therefore included in order to reduce bias by confounding as much as possible. Another 
limitation results from the fact that we performed multiple tests which has inflated the risk of type I 
errors. We have chosen not to adjust our alpha for multiple testing, as this would further reduce the 
power of our statistical tests, but acknowledge that some of our significant findings may very well be 
false positive findings.  
The strengths of the study are the prospective data collection, the large range of compounds 
included, and the fact that the cohort was very homogenous. Associations are therefore less likely to be 
confounded by demographic or socio-economic factors. The BMI of children, when four weeks old, 
was slightly higher compared to the general Dutch, Caucasian population. According to the fifth National 
Growth Study performed in 2009, median BMI at this age was 14.75 for boys, and 14.55 for girls, 
compared to 15.53, and 14.83 for boys and girls respectively in the current study [56]. In one-year-olds, 
median BMI was 17.18 in boys, and 16.76 in girls in the general population, compared to respectively 
17.14, and 16.21 in our cohort, indicating that girls had a slightly lower BMI at this age than would be 
expected. Furthermore, mothers in this cohort have more often received higher education compared to 
the general Dutch population [57], and the sex-ratio (1.7) of the offspring is higher than in general. 
Furthermore the male/female ratio of offspring was 1.7, which is higher than average. We have no 
explanation for this, as the cohort was recruited prospectively. There is no indication that early life 
exposure to EDCs alter male/female ratio [58]. Considering these factors, extrapolation of results to 
other populations should be performed with caution. 
  
Int. J. Environ. Res. Public Health 2014, 11 7017 
 
 
5. Conclusions 
In conclusion, based on our study on first year growth, low exposure to phthalates may be 
associated with a higher BMI over time, which was reflected in both higher weight and height. 
Furthermore there may be an inverse association between DDE exposure and BMI. Results from our 
study should be interpreted with caution due to the limited sample size. Therefore confirmation of our 
results in larger studies is warranted. In addition there is a need for a longer follow-up to examine 
whether these associations persist into later childhood.  
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